Literature DB >> 18187176

Isolation and structural characterization of a new fibrin(ogen)olytic metalloproteinase from Bothrops moojeni snake venom.

Carolina P Bernardes1, Norival A Santos-Filho, Tássia R Costa, Mário S R Gomes, Fernanda S Torres, Júnia Costa, Márcia H Borges, Michael Richardson, Daniel M dos Santos, Adriano M de Castro Pimenta, Maria I Homsi-Brandeburgo, Andreimar M Soares, Fábio de Oliveira.   

Abstract

A proteinase, named BmooMPalpha-I, from the venom of Bothrops moojeni, was purified by DEAE-Sephacel, Sephadex G-75 and heparin-agarose column chromatography. The enzyme was purified to homogeneity as judged by its migration profile in SDS-PAGE stained with coomassie blue, and showed a molecular mass of about 24.5 kDa. Its complete cDNA was obtained by RT-PCR and the 615 bp codified for a mature protein of 205 amino acid residues. The multiple alignment of its deduced amino acid sequence and those of other snake venom metalloproteinases showed a high structural similarly, mainly among class P-IB proteases. The enzyme cleaves the Aalpha-chain of fibrinogen first, followed by the Bbeta-chain, and shows no effects on the gamma-chain. On fibrin, the enzyme hydrolyzed only the beta-chain, leaving the gamma-dimer apparently untouched. It was devoid of phospholipase A(2), hemorrhagic and thrombin-like activities. Like many venom enzymes, it is stable at pH values between 4 and 10 and stable at 70 degrees C for 15 min. The inhibitory effects of EDTA on the fibrinogenolytic activity suggest that BmooMPalpha-I is a metalloproteinase and inhibition by beta-mercaptoethanol revealed the important role of the disulfide bonds in the stabilization of the native structure. Aprotinin and benzamidine, specific serine proteinase inhibitors, had no effect on BmooMPalpha-I activity. Since the BmooMPalpha-I enzyme was found to cause defibrinogenation when administered i.p. on mice, it is expected that it may be of medical interest as a therapeutic agent in the treatment and prevention of arterial thrombosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18187176     DOI: 10.1016/j.toxicon.2007.11.017

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  15 in total

1.  Lys49 myotoxin from the Brazilian lancehead pit viper elicits pain through regulated ATP release.

Authors:  Chuchu Zhang; Katalin F Medzihradszky; Elda E Sánchez; Allan I Basbaum; David Julius
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

2.  cDNA cloning, expression and fibrin(ogen)olytic activity of two low-molecular weight snake venom metalloproteinases.

Authors:  Ying Jia; Sara Lucena; Esteban Cantu; Elda E Sánchez; John C Pérez
Journal:  Toxicon       Date:  2009-04-16       Impact factor: 3.033

3.  Anti-coagulant activity of a metalloprotease: further characterization from the Indian cobra (Naja naja) venom.

Authors:  M S Kumar; V R Devaraj; B S Vishwanath; K Kemparaju
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

4.  Molecular cloning and characterization of cDNAs encoding metalloproteinases from snake venom glands.

Authors:  Ying Jia; John C Pérez
Journal:  Toxicon       Date:  2009-09-30       Impact factor: 3.033

5.  Purification procedure for the isolation of a P-I metalloprotease and an acidic phospholipase A2 from Bothrops atrox snake venom.

Authors:  Danilo L Menaldo; Anna L Jacob-Ferreira; Carolina P Bernardes; Adélia C O Cintra; Suely V Sampaio
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-08-13

6.  P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade.

Authors:  Giselle Pidde-Queiroz; Fábio Carlos Magnoli; Fernanda C V Portaro; Solange M T Serrano; Aline Soriano Lopes; Adriana Franco Paes Leme; Carmen W van den Berg; Denise V Tambourgi
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

7.  Rapid purification of a new P-I class metalloproteinase from Bothrops moojeni venom with antiplatelet activity.

Authors:  Mayara R de Queiroz; Carla C Neves Mamede; Kelly C Fonseca; Nadia C G de Morais; Bruna B de Sousa; Norival A Santos-Filho; Marcelo E Beletti; Eliane C Arantes; Leonilda Stanziola; Fábio de Oliveira
Journal:  Biomed Res Int       Date:  2014-06-01       Impact factor: 3.411

8.  Bmoo FIBMP-I: A New Fibrinogenolytic Metalloproteinase from Bothrops moojeni Snake Venom.

Authors:  F S Torres; B Rates; M T R Gomes; C E Salas; A M C Pimenta; F Oliveira; M M Santoro; M E de Lima
Journal:  ISRN Toxicol       Date:  2012-11-04

9.  Preliminary assessment of Hedychium coronarium essential oil on fibrinogenolytic and coagulant activity induced by Bothrops and Lachesis snake venoms.

Authors:  Cíntia A Sf Miranda; Maria G Cardoso; Mariana E Mansanares; Marcos S Gomes; Silvana Marcussi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-09-01

10.  Purification and characterization of BmooAi: a new toxin from Bothrops moojeni snake venom that inhibits platelet aggregation.

Authors:  Mayara Ribeiro de Queiroz; Carla Cristine N Mamede; Nadia Cristina G de Morais; Kelly Cortes Fonseca; Bruna Barbosa de Sousa; Thaís M Migliorini; Déborah Fernanda C Pereira; Leonilda Stanziola; Leonardo A Calderon; Rodrigo Simões-Silva; Andreimar Martins Soares; Fábio de Oliveira
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.